Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer

被引:29
|
作者
Brown, Justin C. [1 ]
Rhim, Andrew D. [2 ]
Manning, Sara L. [3 ]
Brennan, Luke [3 ]
Mansour, Alexandra I. [3 ]
Rustgi, Anil K. [4 ]
Damjanov, Nevena [4 ]
Troxel, Andrea B. [5 ]
Rickels, Michael R. [4 ]
Ky, Bonnie [4 ]
Zemel, Babette S. [4 ,6 ]
Courneya, Kerry S. [7 ]
Schmitz, Kathryn H. [8 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] NYU, New York, NY USA
[6] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[7] Univ Alberta, Edmonton, AB, Canada
[8] Penn State Coll Med, Hershey, PA USA
来源
PLOS ONE | 2018年 / 13卷 / 10期
基金
美国国家卫生研究院;
关键词
SURROGATE END-POINTS; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; GROWTH-FACTOR; SHEAR-STRESS; BLOOD-FLOW; MORTALITY; SURVIVORS; OBESITY;
D O I
10.1371/journal.pone.0204875
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Physical activity is associated with a lower risk of disease recurrence among colon cancer patients. Circulating tumor cells (CTC) are prognostic of disease recurrence among stage I-III colon cancer patients. The pathways through which physical activity may alter disease outcomes are unknown, but may be mediated by changes in CTCs. Methods Participants included 23 stage I-III colon cancer patients randomized into one of three groups: usual-care control, 150 min-wk-1 of aerobic exercise (low-dose), and 300 min-wk-1 of aerobic exercise (high-dose) for six months. CTCs from venous blood were quantified in a blinded fashion using an established microfluidic antibody-mediated capture device. Poisson regression models estimated the logarithmic counts of CTCs. Results At baseline, 78% (18/23) of patients had >= 1 CTC. At baseline, older age (-0.12+/- 0.06; P=0.04), lymphovascular invasion (0.63+/-0.25; P=0.012), moderate/poor histology (1.09 +/-0.34; P=0.001), body mass index (0.07+/-0.02; P=0.001), visceral adipose tissue (0.08 +/-0.04; P=0.036), insulin (0.06+/-0.02; P=0.011), sICAM-1 (0.04+/-0.02; P=0.037), and sVCAM-1 (0.06+/-0.03; P=0.045) were associated with CTCs. Over six months, significant decreases in CTCs were observed in the low-dose (-1.34+/-0.34; P<0.001) and high-dose (-1.18+/-0.40; P=0.004) exercise groups, whereas no significant change was observed in the control group (-0.59+/-0.56; P=0.292). Over six months, reductions in body mass index (-0.07+/-0.02; P=0.007), insulin (-0.08+/-0.03; P=0.014), and sICAM-1 (-0.07+/-0.03; P=0.005) were associated with reductions in CTCs. The main limitations of this proof-of-concept study are the small sample size, heterogenous population, and per-protocol statistical analysis. Conclusion Exercise may reduce CTCs among stage I-III colon cancer patients. Changes in host factors correlated with changes in CTCs. Exercise may have a direct effect on CTCs and indirect effects through alterations in host factors. This hypothesis-generating observation derived from a small pilot study warrants further investigation and replication.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Circulating tumor cells and circulating tumor DNA in colon cancer
    Fedyanin, Mikhail
    Polyanskaya, Elizaveta
    Tjulandin, Sergei
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2016, 9 (02) : 88 - 92
  • [22] The Association of Abdominal Adiposity With Mortality in Patients With Stage I-III Colorectal Cancer
    Brown, Justin C.
    Caan, Bette J.
    Prado, Carla M.
    Feliciano, Elizabeth M. Cespedes
    Xiao, Jingjie
    Kroenke, Candyce H.
    Meyerhardt, Jeffrey A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (04): : 377 - 383
  • [23] Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer
    Catalano, V.
    Loupakis, F.
    Graziano, F.
    Bisonni, R.
    Torresi, U.
    Vincenzi, B.
    Mari, D.
    Giordani, P.
    Alessandroni, P.
    Salvatore, L.
    Fornaro, L.
    Santini, D.
    Baldelli, A. M.
    Rossi, D.
    Giustini, L.
    Silva, R. R.
    Falcone, A.
    D'Emidio, S.
    Rocchi, M.
    Fedeli, S. Luzi
    ANNALS OF ONCOLOGY, 2012, 23 (01) : 135 - U111
  • [24] Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer
    Cheng, En
    Shi, Qian
    Shields, Anthony F.
    Nixon, Andrew B.
    Shergill, Ardaman P.
    Ma, Chao
    Guthrie, Katherine A.
    Couture, Felix
    Kuebler, Philip
    Kumar, Pankaj
    Tan, Benjamin
    Krishnamurthi, Smitha S.
    Ng, Kimmie
    O'Reilly, Eileen M.
    Brown, Justin C.
    Philip, Philip A.
    Caan, Bette J.
    Cespedes Feliciano, Elizabeth M.
    Meyerhardt, Jeffrey A.
    JAMA ONCOLOGY, 2023, 9 (03) : 404 - 413
  • [25] Dose-response effects of exercise on insulin among colon cancer survivors
    Brown, Justin C.
    Rickels, Michael R.
    Troxel, Andrea B.
    Zemel, Babette S.
    Damjanov, Nevena
    Ky, Bonnie
    Rhim, Andrew D.
    Rustgi, Anil K.
    Courneya, Kerry S.
    Schmitz, Kathryn H.
    ENDOCRINE-RELATED CANCER, 2018, 25 (01) : 11 - 19
  • [26] Preoperative Vertebral Fracture: A Prognostic Factor in Stage I-III Colorectal Cancer
    Kamada, Teppei
    Furukawa, Kenei
    Takahashi, Junji
    Aida, Takashi
    Nakashima, Keigo
    Ito, Eisaku
    Suzuki, Norihiko
    Hata, Taigo
    Ohdaira, Hironori
    Eto, Ken
    Ikegami, Toru
    Suzuki, Yutaka
    ANTICANCER RESEARCH, 2024, 44 (08) : 3533 - 3541
  • [27] Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis
    van de Poll-Franse, L. V.
    Haak, H. R.
    Coebergh, J. W. W.
    Janssen-Heijnen, M. L. G.
    Lemmens, V. E. P. P.
    DIABETOLOGIA, 2012, 55 (08) : 2163 - 2172
  • [28] The relation of presenting symptoms with staging, grading, and postoperative 3-year mortality in patients with stage I-III non-metastatic colon cancer
    Bedir, Osman
    Kiziltas, Safak
    Kostek, Osman
    Ozkanli, Seyma
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2016, 27 (03) : 239 - 245
  • [29] A Cohort Study of Metformin Exposure and Survival in Patients with Stage I-III Colorectal Cancer
    Spillane, Susan
    Bennett, Kathleen
    Sharp, Linda
    Barron, Thomas I.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (08) : 1364 - 1373
  • [30] The Frequency and Determinants of Metabolic Syndrome in Operated Patients with Stage I-III Breast Cancer
    Sarici, Furkan
    Sunar, Veli
    Aksoy, Sercan
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2020, 30 (01): : 1 - 10